Intellectual property and assisted reproductive technology
By David Cyranoski, Jorge L. Contreras & Victoria T. Carrington,
Nature Biotechnology
| 01. 18. 2023
Stanford bioethicist Henry Greely predicts that a large proportion of human pregnancies — perhaps even 90% in the United States — will one day result from in vitro gametogenesis (IVG), the production of eggs and sperm from undifferentiated human cells1. Whether or not this prediction proves accurate, it is likely that IVG will fundamentally change how humans reproduce. IVG could offer the possibility of reproduction to those experiencing infertility, allow parents to choose from hundreds of genetically characterized embryos, enable relatively safe germline genetic modification, and open the door for same-sex parents to have genetically related offspring. Some assisted reproduction experts, like Jacques Cohen of the ART Institute of Washington, predict that IVG will replace virtually all conventional in vitro fertilization (IVF) procedures for those experiencing problems with fertility (J. Cohen, personal communication). Greely suspects that eventually most prospective parents — even those without fertility problems — will opt for IVG to reduce the risk of bearing offspring with genetic defects or to select for desirable traits.
It is not surprising, then, that researchers who are putting together...
Related Articles
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Jason Kehe, Wired | 04.11.2024
God help the babies! Or, absent God, a fertility startup called Orchid. It offers prospective parents a fantastical choice: Have a regular baby or have an Orchid baby. A regular baby might grow up and get cancer. Or be born...
By Neel Shah, The Preprint | 04.11.2024
Years ago, I interviewed for a residency position at The Johns Hopkins Hospital in Baltimore. Standing before the domed Victorian building at the campus entrance, I couldn’t help but be in awe of the history of the place, the great...
By Eleanor Hayward and Joanna Crawford, The Times | 03.29.2024
Gazing out at the Mediterranean from an idyllic rocky mountaintop, Sophie Hermann announced to her half a million Instagram followers that she had decided to freeze her eggs. Since that post in August, the 37-year-old former Made in Chelsea star...